Skip to content
ITIF Logo
ITIF Search
Innovation Files Blog

Innovation Files Blog

Quick takes, quips, and commentary on the latest in tech policy.

August 3, 2026

Fact of the Week: China’s Current Level of Productive Capital Investment Is 8 Times Greater Than That of the United States

China was the world’s largest investor in productive capital in 2024, investing $11.9 trillion when adjusted for purchasing power parity (PPP), equivalent to 31 percent of gross domestic product (GDP). In comparison, the United States invested just $5.1 trillion, or 17 percent of GDP.

July 29, 2026

Comparing Recent Federal Data Privacy Bills

As Congress considers a national data privacy standard, the SECURE Data Act represents a significant shift from earlier proposals. This comparison examines how it differs from the American Privacy Rights Act and the American Data Privacy and Protection Act and why those differences matter for consumers, businesses, and innovation.

July 27, 2026

Waiting for a Better Congress on Data Privacy Won't Work

Waiting for the next Congress is the wrong approach. Because neither party can pass a federal privacy law without bipartisan support, lawmakers should build on the SECURE Data Act's bipartisan, state-tested framework to enact a national privacy law that protects consumers and the economy.

July 27, 2026

USMCA Set the World's Digital Trade Standards Six Years Ago. Now It Can Raise Them

The USMCA’s digital trade rules set the global standard. Now, policymakers should modernize them for the age of AI, close loopholes that enable data localization and discriminatory taxes, and build a more secure, competitive North American digital economy.

July 27, 2026

Fact of the Week: Imposing MFN Pricing on Medicare and Medicaid Will Reduce Global Pharmaceutical R&D Investment by 48 Percent

Applying Most Favored Nation pricing to both Medicare and Medicaid—requiring U.S. prices for drugs that have already been launched to equal the lowest prices among a group of peer countries—is estimated to reduce U.S. pharmaceutical revenues by 49 percent and global pharmaceutical revenues by 31 percent.

July 22, 2026

The FDA Should Not Allow Untested Peptides to Be Added Into Patients’ Medications

The FDA is considering allowing seven unapproved peptides—substantially sourced through a Chinese gray market—to be used by U.S. compounding pharmacies, despite its own scientists warning against it. Approving them would legitimize unvetted foreign suppliers and undermine evidence-based drug regulation.

July 20, 2026

America Needs Both Small and Large Firms

Both small and large firms are essential to America’s innovation system because they specialize in different forms of innovation. Congress should double the regular R&D tax credit to 40 percent and reduce the red tape associated with claiming it.

July 20, 2026

US Manufacturing Labor Productivity Growth Has Stagnated

Manufacturing labor productivity growth is a key driver of the United States’ long-term economic performance and global competitiveness, but it has slowed sharply since 2005. Congress should provide a 25 percent tax credit to firms adopting productivity-enhancing technologies to help reverse this slowdown.

July 20, 2026

Fact of the Week: About 40 Percent of Germany’s GDP Shortfall Is the Result of Declining Export Markets

German exports to China as a share of GDP have declined by more than 40 percent since 2021, while the German labor force has seen a decline of more than 400,000 jobs linked to exports to China.

July 15, 2026

US Spaceports Need More Funding to Prevent a Launch Bottleneck

The United States is the global power in space, but insufficient spaceport infrastructure threatens the growth of the American space industry. Congress, NASA, and Space Force must address the problem before it undermines U.S. leadership.

Back to Top